SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950135-05-003826
Filing Date
2005-07-12
Accepted
2005-07-12 11:45:54
Documents
1
Effectiveness Date
2005-07-12

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. b55837ttdefa14a.htm DEFA14A 43677
  Complete submission text file 0000950135-05-003826.txt   44978
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-21481 | Film No.: 05949740
SIC: 2836 Biological Products, (No Diagnostic Substances)